ZVIA Zevia PBC Insider Trading

Major shareholder De Depot Et Placement sold 2,150,000 ZVIA shares at $1.90 (5/27), reducing stake 15.9%; stock down 56.6% from 52-week high.

De Depot Et Placement Du Quebec Caisse, a 10% owner, sold 2,150,000 shares for $4,085,000 on 2026-05-27, reducing holdings from 13,550,428 to 11,400,428 shares. This represents a substantial 15.9% reduction in the insider's position. The transaction price of $1.90 sits significantly above the current price of $1.59, but well below the 52-week high of $3.66. This insider's prior three sells at ZVIA showed 100% well-timed outcomes at the 90-day mark (-32.5%, -37.5%, and -10.0% respectively), establishing a consistent pattern of selling ahead of subsequent declines at this ticker. Against this backdrop, the underlying company remains unprofitable (net income of $-2,267,000 in latest quarter) with modest annual revenue growth of 4.0%, constraining fundamental support for the stock price.

10% owner CAISSE DE DEPOT ET PLACEMENT DU QUEBEC sold 3,500,000 shares of ZVIA at $2.00 on 2026-01-27 (-20.5% of holdings)

CAISSE DE DEPOT ET PLACEMENT DU QUEBEC, a 10% owner, sold 3,500,000 shares for $7,000,000.00, reducing holdings from 17,050,428 to 13,550,428 shares. The sale occurred at $2.00 per share while the current price stands at $1.89, down 57.0% from the 52-week high and down 18.5% over the prior 30 and 90 days. Zevia itself is unprofitable with net income of $-2,686,000.00 in the latest quarter and annual revenue growth of -6.8%, indicating fundamental deterioration. The insider's cross-ticker track record shows a 100.00% well-timed sell rate with an average 90-day return of -12.5%, though at the same ticker (ZVIA), both prior sells in 2025 were also well-timed at the 90-day mark, suggesting a consistent pattern of exiting before further declines. The timing and scale of this disposition—a 20.5% reduction by a major shareholder amid deteriorating fundamentals and negative price momentum—warrant investor attention.

10% owner CAISSE DE DEPOT ET PLACEMENT DU QUEBEC sold 2,971,664 shares of ZVIA at $2.73 on 2025-09-30; stock now $1.89 (-57.0% from 52-week high).

Caisse de Dépôt et Placement du Québec, a 10% shareholder, sold 2,971,664 shares (2.97M shares) at $2.73, reducing its stake by 14.8% to 17,050,428 shares (17.05M shares) remaining. The stock has since fallen $0.84 to $1.89, placing the current price 57.0% below the 52-week high of $4.40 and trading 30.8% below the transaction price. Against the backdrop of negative fundamentals—the company posted a net income loss of $-2.7M in its latest quarter and annual revenue declined 6.8% year-over-year—the substantial reduction in a major shareholder's position raises questions about confidence in near-term prospects. Notably, the insider's prior sell at ZVIA on 2025-06-30 was well-timed, with a negative 90-day return of -10.0%, suggesting a historical pattern of exiting before downturns at this ticker.

10% owner CAISSE DE DEPOT ET PLACEMENT DU QUEBEC sells 2,000,000 shares (2.00M) of ZVIA at $3.01; exits to 20,022,092 shares (20.02M) post-transaction.

CAISSE DE DEPOT ET PLACEMENT DU QUEBEC, a 10% owner, sold 2,000,000 shares (2.00M shares) representing a -9.1% reduction in its pre-transaction holding, generating $6,020,000.00 ($6.0M) in proceeds. The sale occurs in a challenging fundamental backdrop: the company posted a latest-quarter revenue of $38,023,000.00 ($38.0M) while reporting net income of $-6,371,000.00 ($-6.4M), reflecting ongoing unprofitability alongside -6.8% annual revenue decline year-over-year. The stock is currently down -35.8% from its 52-week high of $4.83, though it has recovered +16.5% over the past 30 days and +42.9% over 90 days, suggesting near-term momentum that has not reversed the structural weakness. A major shareholder's partial exit during a period of negative earnings and deteriorating top-line growth signals a shift in capital allocation by an institutional holder with deep liquidity needs or changing conviction.

Director Ripley Rosemary L sold 2,567,006 shares of ZVIA at $1.90 (12/5/2024); stock up 104.6% in 30 days

Director Ripley Rosemary L executed a substantial sale of 2,567,006 shares at $1.90, reducing her holdings by 48.6% from 5,286,264 shares to 2,719,258 shares. The sale occurred in a context of significant recent price appreciation, with the stock up 104.6% over the preceding 30 days and 195.3% over 90 days, now trading at $3.13 (current price). Zevia remains unprofitable with a net loss of $2,842,000 in the latest quarter and only 2.0% annual revenue growth, creating a disconnect between the recent trading momentum and underlying financial performance. This large, discretionary reduction in position size by a director warrants investor attention to whether the sale reflects a reassessment of valuation risk given the stock's sharp rally against a backdrop of negative earnings.

Chief Commercial Officer DeBow bought 23,455 shares of ZVIA at $2.14 on 2023-11-22, doubling holdings to 44,951 shares amid unprofitability.

DeBow Greig P. Jr., serving as Chief Commercial Officer, purchased 23,455 shares at $2.14, increasing his position by 109.1% from 21,496 to 44,951 shares. The transaction occurred when the stock was near the top of its 52-week range ($0.62–$2.27) and has since declined 53.3%, now trading at $1.06. The company remains unprofitable with a net loss of $6,961,000.00 on quarterly revenue of $40,426,000.00, and posted only 2.0% annual revenue growth. The magnitude of the purchase relative to his prior holdings and the executive's position suggest material personal commitment at a price that has since become significantly underwater.

Director Ruehl Garcia purchases 15,000 shares at $1.03–$1.04 (Sep 5–6); cluster buy pattern emerges as 2 other insiders also acquired within 14 days.

Director Ruehl Garcia completed 2 separate purchases totaling 15,000 shares for $15,592.80 at a blended average price of $1.04, raising her post-transaction holdings to 227,246 shares. This acquisition occurred while the stock trades at $1.00, down 64.5% from its 52-week high of $2.82, despite a recent 30-day rebound of 14.9%. The company reported $40.4M in quarterly revenue with a net loss of $7.0M and recorded negative full-year net income, indicating operational challenges. Notably, this transaction is part of a cluster pattern: 2 other insiders purchased shares within the prior 14 days. The cluster activity, combined with accumulation at depressed valuation levels relative to the 52-week range, merits investor attention to understand whether this reflects informed confidence in a recovery inflection or other strategic reasoning.

Director Ruberti Alexandre purchased 10,000 shares of ZVIA at $0.98, increasing holdings to 94,091 shares (+11.9%)

Director Alexandre purchased 10,000 shares at $0.98 on 2024-09-03, a price 3.9% below the current $1.02 level. The company is unprofitable with net income of $-6,961,000.00 against revenue of $40,426,000.00, and annual revenue growth stands at only +2.0%. While the 30-day price change shows +20.0%, the stock remains -63.8% from its 52-week high of $2.82, indicating sustained weakness. Alexandre's cross-ticker track record shows 1 prior sale with a 100.00% well-timed rate, suggesting prior trading discipline, though this single historical data point provides limited predictive power for this specific ticker's outlook.

Director Lee David J. purchases 13,704 shares of ZVIA at $1.09; stock -61.0% from 52-week high.

Lee David J., a Director, purchased 13,704 shares at $1.09 on 2024-08-26, increasing his holdings to 172,775 shares (+8.6% vs pre-transaction holdings). The purchase occurred as ZVIA trades -61.0% from its 52-week high, though the stock has gained +27.7% over the past 30 days and +23.6% over 90 days. The company generated $40,426,000 in revenue during the latest quarter but reported a net loss of $-6,961,000, with full-year results also unprofitable and only +2.0% annual revenue growth. The buy represents an open-market acquisition by a board member during a period of significant stock depreciation from peak valuations, though the recent upward price momentum suggests some recovery from lows.

Zevia PBC director Andrew buys 9,560 shares at $1.05; holder profitless at -$7.0M net income, +2.0% revenue growth.

Ruben Andrew, a director of Zevia PBC, purchased 9,560 shares at $1.05 on 2024-08-20, establishing an initial holding position. The company is currently unprofitable with net income of -$7.0M against quarterly revenue of $40.4M, and posted only +2.0% annual revenue growth. The purchase occurred at a price -59.6% below the 52-week high of $2.82, and the stock has since moved +32.3% over 30 days and +25.5% over 90 days from the transaction date. As a new position for this director, this transaction reflects entry into ZVIA equity rather than accumulated conviction or portfolio adjustment.